Natural killer cells in human health and disease, Clinical Immunology, vol.118, issue.1, pp.1-10, 2006. ,
DOI : 10.1016/j.clim.2005.10.011
Functions of natural killer cells, Nature Immunology, vol.178, issue.5, pp.503-510, 2008. ,
DOI : 10.1073/pnas.050588297
URL : https://hal.archives-ouvertes.fr/hal-00294184
Natural killer cells and dendritic cells: rendezvous in abused tissues, Nature Reviews Immunology, vol.23, issue.12, pp.957-964, 2002. ,
DOI : 10.1038/nri956
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses, Journal of Virology, vol.79, issue.15, pp.9369-9380, 2005. ,
DOI : 10.1128/JVI.79.15.9369-9380.2005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1181548
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection, Gut, vol.58, issue.7, pp.974-982, 2009. ,
DOI : 10.1136/gut.2008.163600
Therapeutic vaccination in chronic hepatitis B virus carriers, Expert Review of Vaccines, vol.5, issue.5, pp.707-716, 2006. ,
DOI : 10.1586/14760584.5.5.707
Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers, Hepatology, vol.1, issue.Suppl 1, pp.874-882, 2004. ,
DOI : 10.1002/hep.20408
DNA Vaccination: ???Transfection and Activation of Dendritic Cells as Key Events for Immunity, The Journal of Experimental Medicine, vol.8, issue.1, pp.169-178, 1999. ,
DOI : 10.1016/S1074-7613(00)80256-3
CpG motifs: the active ingredient in bacterial extracts?, Nature Medicine, vol.9, issue.7, pp.831-835, 2003. ,
DOI : 10.1038/nm0703-831
DNA Vaccines: Immunology, Application, and Optimization, Annual Review of Immunology, vol.18, issue.1, pp.927-974, 2000. ,
DOI : 10.1146/annurev.immunol.18.1.927
Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA, J Immunol, vol.157, pp.1840-1845, 1996. ,
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans., Proceedings of the National Academy of Sciences, vol.92, issue.12, pp.5307-5311, 1995. ,
DOI : 10.1073/pnas.92.12.5307
DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state., Proceedings of the National Academy of Sciences, vol.93, issue.22, pp.12496-12501, 1996. ,
DOI : 10.1073/pnas.93.22.12496
Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization, The Journal of Immunology, vol.165, issue.8, pp.4748-4755, 2000. ,
DOI : 10.4049/jimmunol.165.8.4748
DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines., Proceedings of the National Academy of Sciences, vol.93, issue.14, pp.7213-7218, 1996. ,
DOI : 10.1073/pnas.93.14.7213
Immunological techniques in viral hepatitis, Journal of Hepatology, vol.46, issue.3, pp.508-520, 2007. ,
DOI : 10.1016/j.jhep.2007.01.002
Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers, Vaccine, vol.24, issue.21, pp.4482-4489, 2006. ,
DOI : 10.1016/j.vaccine.2005.08.013
Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms, Hepatology, vol.30, issue.5, pp.1117-1124, 2000. ,
DOI : 10.1053/jhep.2000.19324
NK cells at the interface between innate and adaptive immunity, Cell Death and Differentiation, vol.178, issue.2, pp.226-233, 2008. ,
DOI : 10.1182/blood-2004-10-4035
TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function, Immunity, vol.21, issue.1, pp.107-119, 2004. ,
DOI : 10.1016/j.immuni.2004.06.007
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells, Proceedings of the National Academy of Sciences, vol.101, issue.27, pp.10116-10121, 2004. ,
DOI : 10.1073/pnas.0403744101
Close encounters of different kinds: Dendritic cells and NK cells take centre stage, Nature Reviews Immunology, vol.166, issue.2, pp.112-124, 2005. ,
DOI : 10.1038/nri1549
Genomic analysis of the host response to hepatitis B virus infection, Proceedings of the National Academy of Sciences, vol.101, issue.17, pp.6669-6674, 2004. ,
DOI : 10.1073/pnas.0401771101
Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection, Gastroenterology, vol.137, issue.4, pp.1287-300, 2009. ,
DOI : 10.1053/j.gastro.2009.06.054
Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections, Gastroenterology, vol.137, issue.3, pp.1151-60, 2009. ,
DOI : 10.1053/j.gastro.2009.05.047
URL : http://hdl.handle.net/2434/223217
Natural killer cells: from ???disturbing??? background to central players of immune responses, Molecular Immunology, vol.42, issue.4, pp.381-383, 2005. ,
DOI : 10.1016/j.molimm.2004.07.016
Molecular Basis of the Dual Functions of 2B4 (CD244), The Journal of Immunology, vol.180, issue.12, pp.8159-8167, 2008. ,
DOI : 10.4049/jimmunol.180.12.8159
Modulation of Natural Killer (NK) Receptors on NK (CD3???/CD56+), T (CD3+/CD56???) and NKT-like (CD3+/CD56+) Cells after Heart Transplantation, NKT-like (CD3+/CD56+) cells after heart transplantation, pp.200-205, 2006. ,
DOI : 10.1016/j.healun.2005.08.007
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell???mediated liver damage, The Journal of Experimental Medicine, vol.266, issue.3, pp.667-680, 2007. ,
DOI : 10.1084/jem.189.2.441
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137916
Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection, The Journal of Immunology, vol.173, issue.10, pp.6072-6081, 2004. ,
DOI : 10.4049/jimmunol.173.10.6072
T cells with PD-1-dependent regulatory activities, Immunology, vol.439, issue.1, pp.73-82, 2007. ,
DOI : 10.1111/j.1365-2567.2006.02479.x
The NKG2D receptor: immunobiology and clinical implications, Immunologic Research, vol.6, issue.Pt 2, pp.18-34, 2008. ,
DOI : 10.1007/s12026-007-0060-9
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor, Proceedings of the National Academy of Sciences, vol.102, issue.31, pp.10846-10851, 2005. ,
DOI : 10.1073/pnas.0502208102
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor, Blood, vol.107, issue.8, pp.3251-3257, 2006. ,
DOI : 10.1182/blood-2005-10-4231
Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells, Hepatology, vol.201, issue.3, pp.706-715, 2007. ,
DOI : 10.1002/hep.21872
IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A- mediated down-regulation of NK cell activation, European Journal of Immunology, vol.25, issue.5, pp.1611-1616, 1998. ,
DOI : 10.1002/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6
Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells, J Immunol, vol.161, pp.3493-3500, 1998. ,
NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses, Blood, vol.113, issue.26, pp.6593-6602, 2009. ,
DOI : 10.1182/blood-2009-01-201467
Human natural killer cells, Blood, vol.112, issue.3, pp.461-469, 2008. ,
DOI : 10.1182/blood-2007-09-077438
URL : https://hal.archives-ouvertes.fr/hal-00431858
Redefining Chronic Viral Infection, Journal of End-to-End-testing, vol.138, issue.1, pp.30-50, 2009. ,
DOI : 10.1016/S9999-9994(09)20378-3
URL : http://dx.doi.org/10.1016/j.cell.2009.06.036
Can NK cells be a therapeutic target in human diseases?, European Journal of Immunology, vol.24, issue.11, pp.2964-2968, 2008. ,
DOI : 10.1002/eji.200838764